Skip to content
lifestyle.clientim.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Praxis Precision Medicines, Inc.
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results
August 6, 2026
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 4, 2026
Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
July 30, 2026
Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference
June 4, 2026
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 2, 2026
Praxis Precision Medicines Provides Vormatrigine Program Update
June 1, 2026
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 7, 2026
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 5, 2026
Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference
May 4, 2026
Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor
April 14, 2026
1
2
Next Page
→